NVCRNovoCure GmbHFinished
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
12Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
- +10
Main results were due Nov 2024, none posted yet
Counts until it's fixed
- +1.7
8 insiders sold shares within a month
Since Jun 4, 2026 · was worth 10, fading over time
Worry score12
Score over time
- Stage
- Phase 3
- Patients
- 298 (final count)
- Started
- Jul 2016
- Main results expected
- Nov 29, 2024
- Fully finished
- Nov 29, 2024
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Time to intracranial progression
Measured over: 3 years
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- results_overdue: base 10, now 10, since 2024-11-29, no fading
- insider_selling_cluster: base 10, now 1.7, since 2026-06-04, fades (half-life)
Raw record changes
- none yet
Trial ID NCT02831959 · record last updated 2025-10-31 · checked 2026-11-09 15:47 UTC